Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Cancer Lett. 2018 Nov 1;442:91–103. doi: 10.1016/j.canlet.2018.10.020

Figure 1. Chemical structure of IPI-549 and cytotoxicity of IPI-549 on parental and drugresistant cells.

Figure 1.

Chemical structure of IPI-549 (A). Cell survival (%) percentage was measured after treatment with IPI-549 for 72 h on parental and drug-resistant cells: SW620 and SW620/AD300 cells (B), LLC-PK1 and LLC-PK-MDR1 cells (C), S1 and S1-M1–80 cells (D). Points with error bars represent the mean ± SD for independent determinations in triplicate. The above figures are representative of three independent experiments.